APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Chickenpox (Varicella) Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Chickenpox (Varicella) Vaccine Market Outlook and Growth Opportunities 2026

Report ID 173977110421 December 2025191 pages

Choose your research edition.

Industry ResearchChickenpox (Varicella) Vaccine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Chickenpox (Varicella) Vaccine Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Chickenpox (Varicella) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chickenpox (Varicella) Vaccine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Chickenpox (Varicella) Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Chickenpox (Varicella) Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Chickenpox (Varicella) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chickenpox (Varicella) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chickenpox (Varicella) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Chickenpox (Varicella) Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Chickenpox (Varicella) Vaccine market include Shanghai Institute, Merck & Co., GSK, Sanofi Pasteur, Keygen, Green Cross, Changsheng, Biken and BCHT, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Chickenpox (Varicella) Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chickenpox (Varicella) Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chickenpox (Varicella) Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chickenpox (Varicella) Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Chickenpox (Varicella) Vaccine Segment by Company

Shanghai Institute

Merck & Co.

GSK

Sanofi Pasteur

Keygen

Green Cross

Changsheng

Biken

BCHT

Chickenpox (Varicella) Vaccine Segment by Type

Monovalent Vaccine

Combination Vaccine

Chickenpox (Varicella) Vaccine Segment by Application

Kids Injection

Adults Injection

Chickenpox (Varicella) Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Chickenpox (Varicella) Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Chickenpox (Varicella) Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Chickenpox (Varicella) Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Chickenpox (Varicella) Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chickenpox (Varicella) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chickenpox (Varicella) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chickenpox (Varicella) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chickenpox (Varicella) Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chickenpox (Varicella) Vaccine industry.

Chapter 3: Detailed analysis of Chickenpox (Varicella) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Chickenpox (Varicella) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Chickenpox (Varicella) Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Chickenpox (Varicella) Vaccine Industry Trends Table 2. Chickenpox (Varicella) Vaccine Industry Drivers Table 3. Chickenpox (Varicella) Vaccine Industry Opportunities and Challenges Table 4. Chickenpox (Varicella) Vaccine Industry Restraints Table 5. Global Chickenpox (Varicella) Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Chickenpox (Varicella) Vaccine Revenue Share by Company (2021-2026) Table 7. Global Chickenpox (Varicella) Vaccine Sales Volume by Company (k units) & (2021-2026) Table 8. Global Chickenpox (Varicella) Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Chickenpox (Varicella) Vaccine Average Price (US$/unit) of Company (2021-2026) Table 10. Global Chickenpox (Varicella) Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Chickenpox (Varicella) Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Chickenpox (Varicella) Vaccine Company, Product Type & Application Table 13. Global Chickenpox (Varicella) Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Chickenpox (Varicella) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Monovalent Vaccine Table 18. Significant Companies of Combination Vaccine Table 19. Global Chickenpox (Varicella) Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Chickenpox (Varicella) Vaccine Sales Volume by Type (2021-2026) & (k units) Table 21. Global Chickenpox (Varicella) Vaccine Sales Volume by Type (2027-2032) & (k units) Table 22. Global Chickenpox (Varicella) Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Chickenpox (Varicella) Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Chickenpox (Varicella) Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Chickenpox (Varicella) Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Chickenpox (Varicella) Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Chickenpox (Varicella) Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Chickenpox (Varicella) Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Kids Injection Table 30. Significant Companies of Adults Injection Table 31. Global Chickenpox (Varicella) Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Chickenpox (Varicella) Vaccine Sales Volume by Application (2021-2026) & (k units) Table 33. Global Chickenpox (Varicella) Vaccine Sales Volume by Application (2027-2032) & (k units) Table 34. Global Chickenpox (Varicella) Vaccine Sales Volume Share by Application (2021-2026) Table 35. Global Chickenpox (Varicella) Vaccine Sales Volume Share by Application (2027-2032) Table 36. Global Chickenpox (Varicella) Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Chickenpox (Varicella) Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Chickenpox (Varicella) Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Chickenpox (Varicella) Vaccine Sales Value Share by Application (2021-2026) Table 40. Global Chickenpox (Varicella) Vaccine Sales Value Share by Application (2027-2032) Table 41. Global Chickenpox (Varicella) Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Chickenpox (Varicella) Vaccine Sales by Region (2021-2026) & (k units) Table 43. Global Chickenpox (Varicella) Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Chickenpox (Varicella) Vaccine Sales by Region (2027-2032) & (k units) Table 45. Global Chickenpox (Varicella) Vaccine Sales Market Share by Region (2027-2032) Table 46. Global Chickenpox (Varicella) Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Chickenpox (Varicella) Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Chickenpox (Varicella) Vaccine Sales Value Share by Region (2021-2026) Table 49. Global Chickenpox (Varicella) Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Chickenpox (Varicella) Vaccine Sales Value Share by Region (2027-2032) Table 51. Global Chickenpox (Varicella) Vaccine Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Chickenpox (Varicella) Vaccine Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Chickenpox (Varicella) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Chickenpox (Varicella) Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Chickenpox (Varicella) Vaccine Sales by Country (2021-2026) & (k units) Table 56. Global Chickenpox (Varicella) Vaccine Sales Market Share by Country (2021-2026) Table 57. Global Chickenpox (Varicella) Vaccine Sales by Country (2027-2032) & (k units) Table 58. Global Chickenpox (Varicella) Vaccine Sales Market Share by Country (2027-2032) Table 59. Global Chickenpox (Varicella) Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Chickenpox (Varicella) Vaccine Sales Value Market Share by Country (2021-2026) Table 61. Global Chickenpox (Varicella) Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Chickenpox (Varicella) Vaccine Sales Value Market Share by Country (2027-2032) Table 63. Shanghai Institute Company Information Table 64. Shanghai Institute Business Overview Table 65. Shanghai Institute Chickenpox (Varicella) Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Shanghai Institute Chickenpox (Varicella) Vaccine Product Portfolio Table 67. Shanghai Institute Recent Development Table 68. Merck & Co. Company Information Table 69. Merck & Co. Business Overview Table 70. Merck & Co. Chickenpox (Varicella) Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Merck & Co. Chickenpox (Varicella) Vaccine Product Portfolio Table 72. Merck & Co. Recent Development Table 73. GSK Company Information Table 74. GSK Business Overview Table 75. GSK Chickenpox (Varicella) Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. GSK Chickenpox (Varicella) Vaccine Product Portfolio Table 77. GSK Recent Development Table 78. Sanofi Pasteur Company Information Table 79. Sanofi Pasteur Business Overview Table 80. Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Sanofi Pasteur Chickenpox (Varicella) Vaccine Product Portfolio Table 82. Sanofi Pasteur Recent Development Table 83. Keygen Company Information Table 84. Keygen Business Overview Table 85. Keygen Chickenpox (Varicella) Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Keygen Chickenpox (Varicella) Vaccine Product Portfolio Table 87. Keygen Recent Development Table 88. Green Cross Company Information Table 89. Green Cross Business Overview Table 90. Green Cross Chickenpox (Varicella) Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Green Cross Chickenpox (Varicella) Vaccine Product Portfolio Table 92. Green Cross Recent Development Table 93. Changsheng Company Information Table 94. Changsheng Business Overview Table 95. Changsheng Chickenpox (Varicella) Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Changsheng Chickenpox (Varicella) Vaccine Product Portfolio Table 97. Changsheng Recent Development Table 98. Biken Company Information Table 99. Biken Business Overview Table 100. Biken Chickenpox (Varicella) Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Biken Chickenpox (Varicella) Vaccine Product Portfolio Table 102. Biken Recent Development Table 103. BCHT Company Information Table 104. BCHT Business Overview Table 105. BCHT Chickenpox (Varicella) Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. BCHT Chickenpox (Varicella) Vaccine Product Portfolio Table 107. BCHT Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Chickenpox (Varicella) Vaccine Distributors List Table 111. Chickenpox (Varicella) Vaccine Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Chickenpox (Varicella) Vaccine Product Image Figure 2. Global Chickenpox (Varicella) Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chickenpox (Varicella) Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Chickenpox (Varicella) Vaccine Sales (2021-2032) & (k units) Figure 5. Global Chickenpox (Varicella) Vaccine Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Chickenpox (Varicella) Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Monovalent Vaccine Image Figure 10. Combination Vaccine Image Figure 11. Global Chickenpox (Varicella) Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Chickenpox (Varicella) Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Chickenpox (Varicella) Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Chickenpox (Varicella) Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Chickenpox (Varicella) Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Chickenpox (Varicella) Vaccine Sales Value Share by Type (2021-2032) Figure 17. Kids Injection Image Figure 18. Adults Injection Image Figure 19. Global Chickenpox (Varicella) Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Chickenpox (Varicella) Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Chickenpox (Varicella) Vaccine Sales Volume Share by Application (2021-2032) Figure 22. Global Chickenpox (Varicella) Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Chickenpox (Varicella) Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Chickenpox (Varicella) Vaccine Sales Value Share by Application (2021-2032) Figure 25. Global Chickenpox (Varicella) Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Chickenpox (Varicella) Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Chickenpox (Varicella) Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Chickenpox (Varicella) Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Chickenpox (Varicella) Vaccine Sales Value (2021-2032) & (US$ Million) Figure 30. North America Chickenpox (Varicella) Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Chickenpox (Varicella) Vaccine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Chickenpox (Varicella) Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Chickenpox (Varicella) Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. South America Chickenpox (Varicella) Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Chickenpox (Varicella) Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Chickenpox (Varicella) Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Chickenpox (Varicella) Vaccine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Chickenpox (Varicella) Vaccine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Monovalent Vaccine
  • Combination Vaccine
Applications
  • Kids Injection
  • Adults Injection
Companies covered
  • Shanghai Institute
  • Merck & Co.
  • GSK
  • Sanofi Pasteur
  • Keygen
  • Green Cross
  • Changsheng
  • Biken
  • BCHT

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Chickenpox (Varicella) Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Chickenpox (Varicella) Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Chickenpox (Varicella) Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Chickenpox (Varicella) Vaccine Market Dynamics
  1. 2.1 Chickenpox (Varicella) Vaccine Industry Trends
  2. 2.2 Chickenpox (Varicella) Vaccine Industry Drivers
  3. 2.3 Chickenpox (Varicella) Vaccine Industry Opportunities and Challenges
  4. 2.4 Chickenpox (Varicella) Vaccine Industry Restraints
3 Chickenpox (Varicella) Vaccine Market by Company
  1. 3.1 Global Chickenpox (Varicella) Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Chickenpox (Varicella) Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Chickenpox (Varicella) Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Chickenpox (Varicella) Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Chickenpox (Varicella) Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Chickenpox (Varicella) Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Chickenpox (Varicella) Vaccine Company Product Type and Application
  8. 3.8 Global Chickenpox (Varicella) Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Chickenpox (Varicella) Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Chickenpox (Varicella) Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Chickenpox (Varicella) Vaccine Market by Type
  1. 4.1 Chickenpox (Varicella) Vaccine Type Introduction
  2. 4.1.1 Monovalent Vaccine
  3. 4.1.2 Combination Vaccine
  4. 4.2 Global Chickenpox (Varicella) Vaccine Sales Volume by Type
  5. 4.2.1 Global Chickenpox (Varicella) Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Chickenpox (Varicella) Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Chickenpox (Varicella) Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Chickenpox (Varicella) Vaccine Sales Value by Type
  9. 4.3.1 Global Chickenpox (Varicella) Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Chickenpox (Varicella) Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Chickenpox (Varicella) Vaccine Sales Value Share by Type (2021-2032)
5 Chickenpox (Varicella) Vaccine Market by Application
  1. 5.1 Chickenpox (Varicella) Vaccine Application Introduction
  2. 5.1.1 Kids Injection
  3. 5.1.2 Adults Injection
  4. 5.2 Global Chickenpox (Varicella) Vaccine Sales Volume by Application
  5. 5.2.1 Global Chickenpox (Varicella) Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Chickenpox (Varicella) Vaccine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Chickenpox (Varicella) Vaccine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Chickenpox (Varicella) Vaccine Sales Value by Application
  9. 5.3.1 Global Chickenpox (Varicella) Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Chickenpox (Varicella) Vaccine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Chickenpox (Varicella) Vaccine Sales Value Share by Application (2021-2032)
6 Chickenpox (Varicella) Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Chickenpox (Varicella) Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chickenpox (Varicella) Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Chickenpox (Varicella) Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Chickenpox (Varicella) Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Chickenpox (Varicella) Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Chickenpox (Varicella) Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Chickenpox (Varicella) Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Chickenpox (Varicella) Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Chickenpox (Varicella) Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Chickenpox (Varicella) Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Chickenpox (Varicella) Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Chickenpox (Varicella) Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Chickenpox (Varicella) Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Chickenpox (Varicella) Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Chickenpox (Varicella) Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Chickenpox (Varicella) Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Chickenpox (Varicella) Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Chickenpox (Varicella) Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Chickenpox (Varicella) Vaccine Sales Value Share by Country, 2025 VS 2032
7 Chickenpox (Varicella) Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Chickenpox (Varicella) Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Chickenpox (Varicella) Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Chickenpox (Varicella) Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Chickenpox (Varicella) Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Chickenpox (Varicella) Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Chickenpox (Varicella) Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Chickenpox (Varicella) Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Chickenpox (Varicella) Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Chickenpox (Varicella) Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Chickenpox (Varicella) Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Chickenpox (Varicella) Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shanghai Institute
  2. 8.1.1 Shanghai Institute Company Information
  3. 8.1.2 Shanghai Institute Business Overview
  4. 8.1.3 Shanghai Institute Chickenpox (Varicella) Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Shanghai Institute Chickenpox (Varicella) Vaccine Product Portfolio
  6. 8.1.5 Shanghai Institute Recent Developments
  7. 8.2 Merck & Co.
  8. 8.2.1 Merck & Co. Company Information
  9. 8.2.2 Merck & Co. Business Overview
  10. 8.2.3 Merck & Co. Chickenpox (Varicella) Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co. Chickenpox (Varicella) Vaccine Product Portfolio
  12. 8.2.5 Merck & Co. Recent Developments
  13. 8.3 GSK
  14. 8.3.1 GSK Company Information
  15. 8.3.2 GSK Business Overview
  16. 8.3.3 GSK Chickenpox (Varicella) Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GSK Chickenpox (Varicella) Vaccine Product Portfolio
  18. 8.3.5 GSK Recent Developments
  19. 8.4 Sanofi Pasteur
  20. 8.4.1 Sanofi Pasteur Company Information
  21. 8.4.2 Sanofi Pasteur Business Overview
  22. 8.4.3 Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Pasteur Chickenpox (Varicella) Vaccine Product Portfolio
  24. 8.4.5 Sanofi Pasteur Recent Developments
  25. 8.5 Keygen
  26. 8.5.1 Keygen Company Information
  27. 8.5.2 Keygen Business Overview
  28. 8.5.3 Keygen Chickenpox (Varicella) Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Keygen Chickenpox (Varicella) Vaccine Product Portfolio
  30. 8.5.5 Keygen Recent Developments
  31. 8.6 Green Cross
  32. 8.6.1 Green Cross Company Information
  33. 8.6.2 Green Cross Business Overview
  34. 8.6.3 Green Cross Chickenpox (Varicella) Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Green Cross Chickenpox (Varicella) Vaccine Product Portfolio
  36. 8.6.5 Green Cross Recent Developments
  37. 8.7 Changsheng
  38. 8.7.1 Changsheng Company Information
  39. 8.7.2 Changsheng Business Overview
  40. 8.7.3 Changsheng Chickenpox (Varicella) Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Changsheng Chickenpox (Varicella) Vaccine Product Portfolio
  42. 8.7.5 Changsheng Recent Developments
  43. 8.8 Biken
  44. 8.8.1 Biken Company Information
  45. 8.8.2 Biken Business Overview
  46. 8.8.3 Biken Chickenpox (Varicella) Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Biken Chickenpox (Varicella) Vaccine Product Portfolio
  48. 8.8.5 Biken Recent Developments
  49. 8.9 BCHT
  50. 8.9.1 BCHT Company Information
  51. 8.9.2 BCHT Business Overview
  52. 8.9.3 BCHT Chickenpox (Varicella) Vaccine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 BCHT Chickenpox (Varicella) Vaccine Product Portfolio
  54. 8.9.5 BCHT Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Chickenpox (Varicella) Vaccine Value Chain Analysis
  2. 9.1.1 Chickenpox (Varicella) Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Chickenpox (Varicella) Vaccine Sales Mode & Process
  6. 9.2 Chickenpox (Varicella) Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Chickenpox (Varicella) Vaccine Distributors
  9. 9.2.3 Chickenpox (Varicella) Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst